Publications by authors named "David Bibi"

Claim this Profile
A
An Evaluation of the Subcutaneous Depot Release of TV-46000, A Novel Long-Acting Injectable (LAI) Formulation of Risperidone, Under Extreme Conditions in Dogs, Minipigs and Humans.
Lilach Steiner, David Bibi, Avia Merenlender Wagner, Pavel Farkas, Safra Rudnick-Glick

Pharmaceutics· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Physiologically-Based Pharmacokinetic Modeling and In Vitro-In Vivo Correlation of TV-46000 (Risperidone LAI): Prediction from Dog to Human.
David Bibi, Raphael Bilgraer, Lilach Steiner, Hussein Hallak

Pharmaceutics· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generic Workflow to Predict Medicine Concentrations in Human Milk Using Physiologically-Based Pharmacokinetic (PBPK) Modelling-A Contribution from the ConcePTION Project.
Nina Nauwelaerts, Julia Macente, Neel Deferm, Rodolfo Hernandes Bonan, Miao-Chan Huang, David Bibi

Pharmaceutics· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and Enantioselective Pharmacokinetic/Pharmacodynamic Analysis of New CNS-Active Sulfamoylphenyl Carbamate Derivatives.
Reem Odi, David Bibi, Bella Shusterman, Natalia Erenburg, Chanan Shaul

Int J Mol Sci· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A perspective on the physicochemical and biopharmaceutic properties of marketed antiseizure drugs-From phenobarbital to cenobamate and beyond.
Reem Odi, David Bibi, Travis Wager, Meir Bialer

Epilepsia· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic analysis of (2S,3S)-sec-butylpropylacetamide (SPD) in rats and pigs-A CNS-active stereoisomer of SPD.
David Bibi, Meir Bialer

Epilepsia· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Stereoselective pharmacokinetic and pharmacodynamic analysis of a CNS-active sulphamoylphenyl carbamate derivative.
David Bibi, Bella Shusterman, Alessio Nocentini, Claudiu T Supuran, Meir Bialer

J Enzyme Inhib Med Chem· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative efficacy of valnoctamide and sec-butylpropylacetamide (SPD) in terminating nerve agent-induced seizures in pediatric rats.
Kari M Haines, Liana M Matson, Emily N Dunn, Cherish E Ardinger, Robyn Lee-Stubbs, David Bibi

Epilepsia· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Comparative Evaluation of the Anticonvulsant Profile, Carbonic-Anhydrate Inhibition and Teratogenicity of Novel Carbamate Derivatives of Branched Aliphatic Carboxylic Acids with 4-Aminobenzensulfonamide.
David Bibi, Hafiz Mawasi, Alessio Nocentini, Claudiu T Supuran, Bogdan Wlodarczyk

Neurochem Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and comparative anticonvulsant activity assessment of CNS-active alkyl-carbamoyl imidazole derivatives.
Hafiz Mawasi, David Bibi, Meir Bialer

Bioorg Med Chem· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic-Pharmacodynamic Correlation and Brain Penetration of sec-Butylpropylacetamide, a New CNS Drug Possessing Unique Activity against Status Epilepticus.
Hafiz Mawasi, David Bibi, Tawfeeq Shekh-Ahmad, Chanan Shaul, Simcha Blotnik

Mol Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis